Search Results
Slidesets
Dutch Example - Mischa Huson, MD, PhD, DTM&H
Presented at:
Demystifying Long COVID International Conference 2024
Slidesets
Challenges with the Implementation of PrEP- Kenneth Mayer, MD
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Slidesets
Revisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination- Fabien Zoulim, MD, PhD
Presented at:
HEP DART 2017
Slidesets
Role of Herbal (and CAMs) in DDIs - Dario Cattaneo, PharmaD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Integrase inhibitors in specific populations- Women and those aging with HIV- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2018
Slidesets
What is the virological support for reduced drug regimens?- Anne-Geneviève Marcelin, MD
Presented at:
European HIV Clinical Forum 2017
Slidesets
People who inject drugs | Olav Dalgard
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
NASH and NAFLD in HIV: same or different? - Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017